Siteman Cancer Center at Saint Peters Hospital
Saint Peters, Missouri, United States
Cancer treatment center in Saint Peters, Missouri
150 Entrance Way, St Peters, MO 63376
About Siteman Cancer Center at Saint Peters Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
99
SWOG Cancer Research Network
28
Pfizer
25
Alliance for Clinical Trials in Oncology
19
NRG Oncology
19
ECOG-ACRIN Cancer Research Group
17
Radiation Therapy Oncology Group
7
Alliance Foundation Trials, LLC.
1
Calliditas Therapeutics Suisse SA
1
Canadian Cancer Trials Group
1
Dana-Farber Cancer Institute
1
Clinical Trials at Siteman Cancer Center at Saint Peters Hospital
During the past decade, Siteman Cancer Center at Saint Peters Hospital conducted 160 clinical trials. In the 10-year time frame, 160 clinical trials started and 59 clinical trials were completed, i.e. on
average, 36.9% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 41 clinical trials were completed. i.e. 87.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
2006-12-13
2011-12-15
Completed
46
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
2007-01-24
2018-09-04
Completed
64
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
2007-07-01
2014-09-01
Completed
223
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma
2009-06-08
2012-10-31
Completed
64
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
2009-04-15
2013-03-17
Completed
637
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
2009-11-01
2014-11-01
Completed
242
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Siteman Cancer Center at Saint Peters Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 99 trials, followed by "SWOG Cancer Research Network" with 28 trials
sponsored, "Pfizer" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored and "NRG Oncology"
with 19 trials sponsored. Other sponsors include 25 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Siteman Cancer Center at Saint Peters Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 91 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator and "Astellas Pharma Inc" with 3 trials as a collaborator. Other collaborators include 20 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Siteman Cancer Center at Saint Peters Hospital
According to Clinical.Site data, the most researched conditions in "Siteman Cancer Center at Saint Peters Hospital" are
"Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Siteman Cancer Center at Saint Peters Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Siteman Cancer Center at Saint Peters Hospital
Most popular intervention types in "Siteman Cancer Center at Saint Peters Hospital" are "Drug" (180 trials), "Other" (103 trials), "Biological" (84 trials), "Procedure" (63 trials) and "Radiation" (59 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (44 trials), "Laboratory Biomarker Analysis" (43 trials), "Computed Tomography" (35 trials), "Biospecimen Collection" (33 trials) and "Questionnaire Administration" (32 trials). Other intervention names were less common.
Clinical Trials Genders at Siteman Cancer Center at Saint Peters Hospital
The vast majority of trials in "Siteman Cancer Center at Saint Peters Hospital" are
189 trials for "All" genders, 20 trials for "Male" genders and 11 trials for "Female" genders.
Clinical Trials Status at Siteman Cancer Center at Saint Peters Hospital
Currently, there are NaN active trials in "Siteman Cancer Center at Saint Peters Hospital".
undefined are not yet recruiting,
78 are recruiting,
92 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 29 completed trials in Siteman Cancer Center at Saint Peters Hospital,
11 suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Siteman Cancer Center at Saint Peters Hospital, 27 "Phase 1"
clinical trials were conducted, 109 "Phase 2" clinical
trials and 103 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".